Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02859519 · ClinicalTrials.gov registry record · Phase 3
A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
A Phase 3 study of Distal, Subungual Onychomycosis, sponsored by Moberg Pharma AB.
- Completed
- Registry status
- Phase 3
- Development phase
- 365
- Enrollment target
- 10
- Study locations
NCT02859519: Completed Phase 3 study of Distal, Subungual Onychomycosis, sponsored by Moberg Pharma AB.
NCT02859519 is a Phase 3 study of Distal, Subungual Onychomycosis that has completed, run by Moberg Pharma AB. The registered enrollment target is 365 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (53% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02859519, a Phase 3 study of Distal, Subungual Onychomycosis, has completed, sponsored by Moberg Pharma AB.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 365 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO). The secondary objective is to evaluate the safety of topical MOB015B in patients with mild to moderate DSO.
Primary Outcome
Complete cure was defined as negative fungal culture of dermatophytes, negative direct potassium hydroxide (KOH) microscopy and 0% clinical disease involvement of the target toenail.
Conditions Studied
Interventions
- DRUG MOB015B
- DRUG MOB015B Vehicle
Study Locations (10)
California
- - Multiple Locations
Florida
- - Multiple Locations
Idaho
- - Multiple Locations
Illinois
- - Rolling Meadows
Minnesota
- - Fridley
New Jersey
- - Multiple Locations
Oregon
- - Multiple Locations
Texas
- - Multiple Locations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-11-13 |
| Phase | Phase 3 |
What the finished NCT02859519 record still lists
NCT02859519 is an interventional study that assigns participants to a tested intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Distal, Subungual Onychomycosis appearing as the primary indexed condition, and to 2 interventions - of which MOB015B is the first listed.
NCT02859519 lists 10 locations in 10 states (California, Florida, Idaho).
Frequently Asked Questions
What is clinical trial NCT02859519 about?
NCT02859519 is a clinical study titled "A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)". The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO). The secondary objective is to evaluate the safety of topical MOB015B in patients with mild to moderate DSO.
What is the current status of trial NCT02859519?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 365 participants. The study started on 2016-10. Estimated completion is 2019-11-13.
What conditions does trial NCT02859519 study?
This clinical trial studies the following conditions: Distal, Subungual Onychomycosis.
What interventions are being tested in trial NCT02859519?
The interventions under investigation include: MOB015B (DRUG), MOB015B Vehicle (DRUG).
Who is sponsoring clinical trial NCT02859519?
This trial is sponsored by Moberg Pharma AB, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02859519 being conducted?
This trial has 10 study locations across California, Florida, Idaho, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Distal, Subungual Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02859519's enrollment target sits among peer trials
365 1001st of 2000 higher than 998 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia